TITLE:
CPG 7909 in Patients With Cutaneous T-Cell Lymphoma

CONDITION:
Lymphoma, T-Cell, Cutaneous

INTERVENTION:
PF-3512676

SUMMARY:

      To assess the effect of CPG 7909 Injection on Cutaneous T-cell lymphoma and the safety of
      CPG 7909 Injection in patients with this cancer.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

        Patients 18 years or older with biopsy (histopathologically) confirmed cutaneous T-cell
        lymphoma (limited to mycosis fungoides (MF)) who have had prior therapy with at least one
        and no more than 3 systemic treatments.

        Exclusion Criteria:

        Patients with visceral involvement, serious infection or illness including human
        immunodeficiency virus infection, or a Karnofsky Performance Status (KPS) < 60 will be
        excluded.
      
